Schedule 13D ownership disclosure

ANEBULO PHARMACEUTICALS INC

Common Stock, par value $0.001 · CUSIP: 034569103

Event date: 2025-02-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Aron R. EnglishReported CIK 0001770436

    Shares: 21,929,880.00 · Class: 51.1%

  • 22 NW FUND, LPReported CIK 0001640809

    Shares: 17,170,877.00 · Class: 40.1%

  • PHARMA INVESTORS, LLC

    Shares: 4,654,528.00 · Class: 11.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-008451
Form type
SCHEDULE 13D/A
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Feb 27, 2025
Reporting period
Feb 24, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub